Business Wire

Great Bay Bio was Founded to Build a Platform for CMC Technology and Pre-Clinical Research and Development of Big Data Services for Innovative Drugs, Dr. Michael Chan as CEO

HONG KONG--(BUSINESS WIRE)--Great Bay Bio, a leading biotechnology company dedicated to innovative drug CMC (Chemistry Manufacturing and Controls) and pre-clinical development of big data service ...
Morningstar

CrossBridge Bio Wins “Best Drug Developer” at 2025 World ADC Awards

Recognition underscores CrossBridge Bio’s leadership in advancing next-generation dual-payload ADCs toward the clinic. CrossBridge Bio, a biopharmaceutical company pioneering next-generation ...
Business Wire

Weave Bio Announces $10M in New Funding and Launch of Its AI-Powered Platform to Streamline Drafting, Reviewing & Submitting Regulatory Documents in Drug Development

NEW HAVEN, Conn.--(BUSINESS WIRE)--Weave Bio, an AI-native life sciences platform company, announced the public release of its flagship offering, AutoIND, and seed funding of $10M co-led by Innovation ...
Contract Pharma

RoukenBio, AVS Bio Form Antibody‑Development Partnership

RoukenBio and AVS Bio have formed a strategic partnership aimed at streamlining the development of therapeutic antibodies.
GEN

Gene Therapy Developer Passage Bio Files for $125M IPO

James M. Wilson, MD, PhD, director of the Gene Therapy Program at the University of Pennsylvania, and a co-founder of Passage Bio. Passage Bio, a developer of gene therapies for rare monogenic CNS ...